BD MaxGuard Extension Set with 4-way stopcock, REF: M4058

FDA Device Recall #Z-1752-2022 — Class II — August 1, 2022

Recall Summary

Recall Number Z-1752-2022
Classification Class II — Moderate risk
Date Initiated August 1, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm CAREFUSION
Location San Diego, CA
Product Type Devices
Quantity 46,900

Product Description

BD MaxGuard Extension Set with 4-way stopcock, REF: M4058

Reason for Recall

Administration set, and extension set product labels list expiration year 2027 but the labels should list expiration year 2025. If expired product is used, the integrity of the product may be compromised, and may result in potential leaks and risk of infection to the patient and healthcare worker.

Distribution Pattern

US: TN, FL, LA, VA, MI, OH, NC, WA, UT, TX, NV, AL, AR, IA, MA, CO, NY, SC, IN, KY, MO, MD, PA, CA, IL, SD, GA, MS, AZ, WV, ID, WY, VT, NM, OR, NJ, OK, KS, MN

Lot / Code Information

UDI-DI: 10885403235788, Lots: 22019324, 22019323, 22019322

Other Recalls from CAREFUSION

Recall # Classification Product Date
Z-1756-2022 Class II BD MaxGuard Drop Administration set with 3 Need... Aug 1, 2022
Z-1760-2022 Class II BD MaxGuard 15 Drop Administration Set with 4 N... Aug 1, 2022
Z-1754-2022 Class II BD MaxGuard Flow Controller Extension Set with ... Aug 1, 2022
Z-1755-2022 Class II BD MaxGuard Flow Controller Extension Set with ... Aug 1, 2022
Z-1753-2022 Class II BD MaxGuard Extension Set, REF: ME1069 Aug 1, 2022

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.